Skip to main content
Watch Insiders
KALV filings

Corporate insider profile

Benjamin L Palleiko Filing Activity

Latest reported as CHIEF EXECUTIVE OFFICER of KalVista Pharmaceuticals, Inc. (KALV).

Purchase filings
0
Reported companies
1
Net open-market value
-$604,654.68
Latest transaction
May 22, 2026

Affiliated corporations

Reported company relationships

KALVLatest reported

KalVista Pharmaceuticals, Inc.

CHIEF EXECUTIVE OFFICER

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 22, 2026KalVista Pharmaceuticals, Inc. (KALV)CHIEF EXECUTIVE OFFICERSale10,926$26.78$292,646
May 18, 2026KalVista Pharmaceuticals, Inc. (KALV)CHIEF EXECUTIVE OFFICERSale1,129$26.76$30,212
May 12, 2026KalVista Pharmaceuticals, Inc. (KALV)CHIEF EXECUTIVE OFFICERSale3,322$26.71$88,731
Subscribe to see more data